Hindered dissolution of fibrin formed under mechanical stress.
BACKGROUND
Recent data indicate that stretching forces cause a dramatic decrease in clot volume accompanied by gross conformational changes of fibrin structure.


OBJECTIVE
The present study attempts to characterize the lytic susceptibility of fibrin exposed to mechanical stress as a model for fibrin structures observed in vivo.


RESULTS
The relevance of stretched fibrin models was substantiated by scanning electron microscopic (SEM) evaluation of human thrombi removed during surgery, where surface fibrin fibers were observed to be oriented in the direction of shear forces, whereas interior fibers formed a random spatial meshwork. These structural variations were modeled in vitro with fibrin exposed to adjustable mechanical stress. After two- and three-fold longitudinal stretching (2 × S, 3 × S) the median fiber diameter and pore area in SEM images of fibrin decreased two- to three-fold. Application of tissue plasminogen activator (tPA) to the surface of model clots, which contained plasminogen, resulted in plasmin generation which was measured in the fluid phase. After 30-min activation 12.6 ± 0.46 pmol mm(-2) plasmin was released from the non-stretched clot (NS), 5.5 ± 1.11 pmol mm(-2) from 2 × S and 2.3 ± 0.36 pmol mm(-2) from 3 × S clot and this hampered plasmin generation was accompanied by decreased release of fibrin degradation products from stretched fibrins. Confocal microscopic images showed that a green fluorescent protein-fusion variant of tPA accumulated in the superficial layer of NS, but not in stretched fibrin.


CONCLUSIONS
Mechanical stress confers proteolytic resistance to fibrin, which is a result of impaired plasminogen activation coupled to lower plasmin sensitivity of the denser fibrin network.
Department of Medical Biochemistry, Semmelweis University, Budapest, Hungary.
I
I
Varjú
P
P
Sótonyi
R
R
Machovich
L
L
Szabó
K
K
Tenekedjiev
M M C G
MM
Silva
C
C
Longstaff
K
K
Kolev
D000368:Aged; D000369:Aged, 80 and over; D001777:Blood Coagulation; D005260:Female; D005337:Fibrin / Q000737:chemistry* / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006801:Humans; D008297:Male; D008855:Microscopy, Electron, Scanning / Q000379:methods; D008875:Middle Aged; D010958:Plasminogen / Q000378:metabolism; D013314:Stress, Mechanical; D013927:Thrombosis / Q000473:pathology; D010959:Tissue Plasminogen Activator / Q000378:metabolism
D049452:Green Fluorescent Proteins; D005337:Fibrin; D010958:Plasminogen; D010959:Tissue Plasminogen Activator; D005341:Fibrinolysin
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):276-82
19910643
J Thromb Haemost. 2007 Apr;5(4):804-11
17408411
Thromb Haemost. 1989 Dec 29;62(4):1083-7
2515603
Blood. 2005 Dec 1;106(12):3824-30
16091450
Curr Med Chem Cardiovasc Hematol Agents. 2005 Oct;3(4):341-55
16250865
Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2567-73
16917107
Blood. 1992 Mar 15;79(6):1420-7
1547340
Methods Enzymol. 1976;45:156-76
1011989
FEBS J. 2008 Mar;275(6):1274-82
18279394
Thromb Haemost. 2010 Dec;104(6):1281-4
20886193
Blood Cells Mol Dis. 2009 Jan-Feb;42(1):51-6
19054699
Biochemistry. 1998 Jun 23;37(25):9112-8
9636057
Med Eng Phys. 2002 Nov;24(9):575-86
12376044
J Biol Chem. 2003 Jun 13;278(24):21331-5
12642590
Circ Res. 2002 Mar 8;90(4):428-34
11884372
Cardiovasc Hematol Agents Med Chem. 2008 Jul;6(3):161-80
18673231
Science. 2009 Aug 7;325(5941):741-4
19661428
J Biol Chem. 1994 Jun 24;269(25):17030-4
7516329
Arterioscler Thromb Vasc Biol. 2000 May;20(5):1354-61
10807754
Thromb Haemost. 2000 Jul;84(1):83-7
10928475
Blood. 2011 Jan 13;117(2):661-8
20966169
Blood. 1994 Feb 15;83(4):982-93
8111066
J Thromb Haemost. 2010 Dec;8(12):2826-8
20961393
J Biol Chem. 1997 May 23;272(21):13666-75
9153217
Science. 1970 Dec 4;170(3962):1095-6
5475635
Thromb Haemost. 2000 Mar;83(3):469-74
10744155